» Articles » PMID: 21225196

Cryptococcus Neoformans Var. Grubii - Pathogenicity of Environmental Isolates Correlated to Virulence Factors, Susceptibility to Fluconazole and Molecular Profile

Overview
Date 2011 Jan 13
PMID 21225196
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The pathogenicity of Cryptococcus neoformans is heterogeneous and is associated with the expression of virulence factors. This study aimed to correlate the pathogenicity of C. neoformans var. grubii in BALB/c mice with in vitro virulence factors, fluconazole minimal inhibitory concentrations (MICs) and molecular profiles, before and after animal passage. Ten environmental isolates and one ATCC strain of C. neoformans var. grubii mating type α were evaluated. Most isolates (91%) killed 50% or more of the infected animals by day 24 postinfection and were recovered from the lungs and brains of surviving animals on days 7 and 14 postinfection. The burden of yeast in the lungs was more variable than that in the brain. The differences in the expression of virulence factors (growth at 37ºC, presence and size of the capsule and production of melanin, urease, proteinase and phospholipase) by most isolates pre and postpassage in animals were not statistically significant. The fluconazole MICs in postpassaged lines differed by a one-dilution from the MIC of the corresponding prepassaged line for six isolates. Using molecular typing [polymerase chain reaction-fingerprinting with (GACA)4 and M13], eight isolates were identified as VNI and three as VNII. We concluded that different isolates with the same molecular and phenotypic profiles, including isolates that are markedly hypervirulent, span a wide range of virulence and there were no changes in virulence factors in the postpassaged lines when compared with the corresponding nonpassaged lines.

Citing Articles

Genotyping Analysis of and Correlation with Virulence Factors and Antifungal Susceptibility by the Clinical and Laboratory Standards Institute and the European Committee on Antifungal Susceptibility Testing Methods.

Andrade-Silva L, Vilas-Boas A, Ferreira-Paim K, Andrade-Silva J, Santos D, Ferreira T J Fungi (Basel). 2023; 9(9).

PMID: 37754997 PMC: 10532325. DOI: 10.3390/jof9090889.


First report of environmental isolation of Cryptococcus and Cryptococcus-like yeasts from Boyacá, Colombia.

Serna-Espinosa B, Forero-Castro M, Morales-Puentes M, Marcela Parra-Giraldo C, Escandon P, Sanchez-Quitian Z Sci Rep. 2023; 13(1):15755.

PMID: 37735454 PMC: 10514045. DOI: 10.1038/s41598-023-41994-6.


Environmental Status of and in Colombia.

Serna-Espinosa B, Guzman-Sanabria D, Forero-Castro M, Escandon P, Sanchez-Quitian Z J Fungi (Basel). 2021; 7(6).

PMID: 34073882 PMC: 8225054. DOI: 10.3390/jof7060410.


Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors.

Andrade-Silva L, Ferreira-Paim K, Ferreira T, Vilas-Boas A, Mora D, Manzato V PLoS One. 2018; 13(3):e0193237.

PMID: 29505557 PMC: 5837091. DOI: 10.1371/journal.pone.0193237.


Cryptococcus-Epithelial Interactions.

Taylor-Smith L J Fungi (Basel). 2018; 3(4).

PMID: 29371569 PMC: 5753155. DOI: 10.3390/jof3040053.